Safer Prescriptions: Using Genetics to Determine the Right Drug Dose.
This Act aims to enhance patient safety by integrating genetic testing (pharmacogenomics) into drug prescription processes. It mandates updating national plans for preventing adverse drug events and requires electronic health record systems to automatically alert providers about potential drug-gene interactions based on a patient's genetic profile. Citizens will benefit from more personalized and safer medical treatment, significantly reducing the risk of severe side effects.
Key points
Personalized Medicine Alerts: Electronic health records must be improved to automatically flag potential drug-gene interactions before a prescription is finalized, ensuring the patient receives the safest medication and dosage.
Professional Education: Healthcare providers, including doctors and pharmacists, will receive new guidance on how to use pharmacogenomic testing to prevent adverse drug reactions.
Improved Reporting: The FDA Adverse Event Reporting System will be updated to allow easier reporting of side effects, including the option to specify if the event was linked to a drug-gene interaction.
Introduced
Citizen Poll